Two more cancer sufferers have vented their anger at health officials for refusing to pay for a life-extending drug.

Victor and Amy Armstrong, of Garsington, plan to appeal after Oxfordshire NHS Primary Care Trust decided against prescribing Mr Armstrong the £2,500-a-month drug Sunitinib.

The grandparents are even considering selling their house to fund the treatment - which is available in other counties, but is not paid for by Oxfordshire PCT.

And Oxford grandfather Frank Eacups, 63, is angry he will not be put forward for consideration for the treatment by the PCT.

Mrs Armstrong, 59, who has herself battled cancer twice, said she was devastated by the decision. Her husband saw it as a gross betrayal.

Mr Armstrong, 62, was diagnosed with kidney cancer in December 2005 and prostate cancer just over a year later. The bricklayer learned last November that it had spread to his lungs.

He said: "I'm thinking of buying the drug myself. I could sell my house."

Mrs Armstrong added: "It's disgusting. I'm so bitter.

"My husband is still working and putting into the system. He has worked for 45 years and he has never claimed a penny."

Fifteen patients in Oxfordshire have been refused Sunitinib by the PCT.

Only one patient, Stephen Dallison, of Iffley Road, Oxford, has had the decision reversed on appeal.

Mr Eacups, who lives in Trafford Road, Headington Quarry, was diagnosed with kidney cancer in March last year. The disease has since spread to his lungs.

He said of Sunitinib: "I know that it would not give me an extra 30 years and it is not a cure - but it would have extended how long I have left."

Oxfordshire PCT refuses to discuss individual cases, but said its policy after research and cost-effectiveness was not to routinely fund Sunitinib.

Dr Ljuba Stirzaker, of Oxfordshire PCT, added: "Each patient's case is considered on its own merits and in the light of all available clinical information.

"The PCT will always consider whether there is a basis for providing this treatment for an individual patient as an exception."

Although it is licensed for use in the UK, the National Institute for Clinical Excellence (Nice) is only expected to give a ruling on doctors prescribing Sunitinib next year.

In the meantime, only 27 of 152 NHS primary care trusts, including Gloucestershire, fund the drug.

Dr Stirzaker said that if a patient moved house to another PCT area where Sunitinib was funded, then they would be prescribed the drug if they met the local PCT's criteria.

However, Gloucestershire PCT said questions would be asked if patients simply jumped county boundaries and tried to register with a GP.